Recanalization of prostatic artery chronic total occlusion prior to prostatic artery embolization.

Radiol Case Rep

Division of Interventional Radiology, Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, 757 Westwood Plaza, Suite #2125, CA 90095, USA.

Published: April 2019

Urinary obstruction secondary to benign prostatic hyperplasia is a late manifestation of the disease, and a poor prognostic sign for responding to conservative therapies. Prostatic artery embolization - when performed successfully - can be an effective treatment for reducing obstructive urinary symptoms. Outlined in this report is the successful recanalization of a prostatic artery chronic total occlusion prior to embolization in an 89-year-old man with benign prostatic hyperplasia, who initially presented with urinary obstruction. Prostatic artery recanalization was possible using a specialized crossing technique from peripheral arterial disease interventions, and allowed for more distal embolization of the prostate gland. This technique may be useful when advanced atherosclerotic disease limits the feasibility and clinical success of prostatic artery embolization.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374614PMC
http://dx.doi.org/10.1016/j.radcr.2019.01.017DOI Listing

Publication Analysis

Top Keywords

prostatic artery
24
artery embolization
12
recanalization prostatic
8
artery chronic
8
chronic total
8
total occlusion
8
occlusion prior
8
urinary obstruction
8
benign prostatic
8
prostatic hyperplasia
8

Similar Publications

BACKGROUND Despite its surgical complexity, kidney transplantation (KT) with multiple renal arteries (MRA) is comparable in performance to KT with a single renal artery (SRA). This study aimed to evaluate the effect of MRA and to investigate risk factors for graft loss in living-donor KT with MRA. MATERIAL AND METHODS This study included living-donor KT recipients who underwent KT in our hospital from February 2002 to March 2023.

View Article and Find Full Text PDF

Potential beneficial impacts of tadalafil on cardiovascular diseases.

J Chin Med Assoc

January 2025

Department and Institute of Pharmacology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.

Tadalafil is a selective phosphodiesterase type 5 (PDE5) inhibitor commonly used for the treatment of erectile dysfunction and benign prostatic hyperplasia. Its mechanism of action involves the inhibition of PDE5, leading to increased levels of nitric oxide and cyclic guanosine monophosphate in the corpus cavernosum, which facilitates smooth muscle relaxation. This article reviews studies using tadalafil in the treatment of cardiovascular diseases and emphasizes its potential advantages in conditions such as pulmonary arterial hypertension, atherosclerosis, coronary artery disease, myocardial infarction, heart failure, stroke, diabetic ulcers, and cardiomyopathy.

View Article and Find Full Text PDF

Background: Androgen deprivation is associated with erectile dysfunction (ED). In different animal models, sulfur dioxide (SO) donors NaSO and NaHSO reduced oxidative stress, fibrosis, and inflammation which contribute to the pathogenesis of androgen deprivation-induced ED, however the effect of SO donors on ED in castrated rats were not known.

Objective: To investigate the therapeutic effect of SO donors, NaSO/NaHSO, on ED in castrated rat model.

View Article and Find Full Text PDF

Background: Patients undergoing surgery often experience stress and anxiety, which can increase complications and hinder recovery. Effective management of these psychological factors is key to improving outcomes. Preoperative anxiety is inversely correlated with the amount of information patients receive, but accessible, personalized support remains limited, especially in preoperative settings.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!